After a Long Interference Proceeding, HDC Opens Up District Court Litigation Against Intel

  • July 23, 2020
  • Category: New Patent Litigation
    Market Sector: Semiconductors

Publicly traded Health Discovery Corporation (HDC) has sued Intel (6:20-cv-00666) over four pattern recognition patents identified as teaching “Support Vector Machine-Recursive Feature Elimination” (SVM-RFE) methods. Intel is accused of infringement through the provision of certain processors, Field Programmable Gate Arrays (FPGAs), Systems-on-Chip (SoCs), and software that are “tested, validated, verified, and optimized” allegedly using the “SVM-RFE” method. HDC and Intel have a history, with the Patent Trial and Appeal Board (PTAB) presiding over a near decade long interference between the two.


View full article with free 30-day trial
($79/month thereafter)


  • Over 7,000 news articles covering new patent cases, key policy decisions, and USPTO assignments
  • Advanced custom alerts for campaigns and entities
  • Proprietary litigation timelines
  • Full access to Federal Circuit, PTAB, and ITC dockets
  • Judge, venue, and law firm analytics



×
×

Thank you for your feedback

×
×